Status:
COMPLETED
Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Evaluate the proportion of hyperlipaemic persons with known coronary heart disease achieving ldl-c goal as defined by the national cholesterol education program (NCEP) adult treatment panel (ATP) III ...
Eligibility Criteria
Inclusion
- Patients who are naïve to lowering lipid agent
- Patients who are treated with lowering lipid agents and had a wash-out period for 4 weeks.
Exclusion
- Impaired kidney function
- Increased liver enzyme levels
- Pregnant women
- Hypersensitivity to ezetimibe and other statin agents
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
229 Patients enrolled
Trial Details
Trial ID
NCT00442897
Start Date
September 1 2006
End Date
October 1 2008
Last Update
May 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.